Overview

Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if a reduction in the enzyme 1-hydroxylase, which activates Vitamin D, is the cause of overactivity of the parathyroid glands (called secondary hyperparathyroidism - normal blood calcium and elevated parathyroid hormone) in a selected group of young patients with normal kidney function.
Phase:
N/A
Details
Lead Sponsor:
University of Maryland
University of Maryland, Baltimore
Treatments:
Ergocalciferols
Teriparatide
Vitamin D
Vitamins